US Food and Drug Administration approves Brilinta tablets for longer-term use in patients with a history of heart attackAstraZeneca received a much-needed boost when its blood-thinning drug, Brilinta, a potential blockbuster, was approved by the US health regulator for wider use.The Food and Drug Administration approved Brilinta tablets for longer-term use in patients with a history of heart attack.